Skip to main navigation Skip to search Skip to main content

Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: Results from two randomized clinical trials of bupropion

  • Sean P. David
  • , David R. Strong
  • , Adam M. Leventhal
  • , Molly A. Lancaster
  • , John E. Mcgeary
  • , Marcus R. Munafò
  • , Andrew W. Bergen
  • , Gary E. Swan
  • , Neal L. Benowitz
  • , Rachel F. Tyndale
  • , David V. Conti
  • , Richard A. Brown
  • , Caryn Lerman
  • , Raymond Niaura
  • Stanford University
  • SRI International
  • The Warren Alpert Medical School
  • University of California, San Diego
  • University of Southern California
  • Phoenix VA Health Care System
  • Department of Experimental Psychology
  • University of Bristol
  • University of California San Francisco
  • University of Toronto
  • University of Pennsylvania
  • John Hopkins University

Research output: Contribution to journal › Article › peer-review

33   Link opens in a new tab Citations (SciVal)

Fingerprint

Dive into the research topics of 'Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: Results from two randomized clinical trials of bupropion'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Neuroscience

Psychology